Press Release

Global HIV/AIDS Drugs Market Movements by Trend Analysis, Growth Status, Revenue Expectation to 2026 | Research Report by Fortune Business Insights

HIV/AIDS Drugs Market – Business Revenue, Future Growth, Trends Plans, Top Key Players, Business Opportunities, Industry Share, Global Size Analysis by Forecast to 2026 | Fortune Business Insights

The global HIV/AIDS drugs market is likely to derive growth form the increasing prevalence of the disease across the world. According to a report published by Fortune Business Insights, titled “HIV/AIDS Drugs Market: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 25,314.0 Mn in 2018. Fortune Business Insights has predicted that the market will reach US$ 40,675.0 Mn by 2026, thereby exhibiting a CAGR of 6.1% in the forecast period

List of players leading the Global AIDS Drugs Market include

  • ViiV Healthcare
  • Gilead Sciences
  • Merck Sharp & Dohme
  • Bristol-Myers Squibb Company
  • Janssen Pharmaceuticals
  • Theratechnologies
  • Mylan Pharmaceuticals
  • Genentech
  • AbbVie

The increasing awareness regarding the severity of HIV AIDS as created a huge emphasis on several drugs, related to the treatment of this disease. The side effects of HIV/AIDS have led to several drug innovations, particularly aimed at efficient treatment of patients with advanced stages of the disease. The report encompasses several factors that have contributed to the growth of the global market in recent years. Besides growth stimulators, the report highlights a few of the factors that have restrained market growth in recent years.

Global HIV Drugs Market Segmentation

By Drug Class

  • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
  • Integrase Inhibitors
  • Combination HIV Medicines
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Geography

  • North America (the USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Rest of the World

More Trending Topics From Fortune Business [email protected]

Population Health Management Market 2020 – 2026, Details in Relation to the Value, Supply Chain Analysis and Recent Technological Developments

Deep Brain Stimulation Systems Market 2020 – 2026, Details in Relation to the Value, Supply Chain Analysis and Recent Technological Developments

Surgical Navigation Systems Market 2020 – 2026, Details in Relation to the Value, Supply Chain Analysis and Recent Technological Developments

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close